FdaApplication

ANDA 209474

Back to search

Identifiers

Properties

PropertyValue
applicant_namePRINSTON PHARMACEUTICAL INC
application_typeANDA
approval_date2022-03-28

Products (1)

ProductActive ingredientStrengthDosage form
LEVETIRACETAMLEVETIRACETAM500MG/5ML (100MG/ML)INJECTABLE;INTRAVENOUS

1 product